Filing Details
- Accession Number:
- 0001708138-21-000082
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-15 16:03:54
- Reporting Period:
- 2021-09-13
- Accepted Time:
- 2021-09-15 16:03:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1174475 | S Michael Brown | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-13 | 2,479 | $380.95 | 3,370 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-09-13 | 3,613 | $413.33 | 6,983 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-09-13 | 3,612 | $413.33 | 10,595 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-13 | 100 | $636.74 | 10,495 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 200 | $637.29 | 10,295 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 676 | $638.64 | 9,619 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 203 | $639.20 | 9,416 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 100 | $640.77 | 9,316 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 100 | $641.12 | 9,216 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 400 | $642.62 | 8,816 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 100 | $643.49 | 8,716 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 100 | $644.89 | 8,616 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 100 | $645.66 | 8,516 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 100 | $646.28 | 8,416 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 151 | $647.58 | 8,265 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 962 | $648.48 | 7,303 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 838 | $649.46 | 6,465 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 1,800 | $650.40 | 4,665 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 3,712 | $651.10 | 953 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-13 | 62 | $652.26 | 891 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-09-13 | 2,479 | $0.00 | 2,479 | $380.95 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-09-13 | 3,613 | $0.00 | 3,613 | $413.33 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-09-13 | 3,612 | $0.00 | 3,612 | $413.33 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-01-02 | No | 4 | M | Direct | |
| 3,612 | 2025-01-02 | No | 4 | M | Direct | |
| 0 | 2025-01-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,000 | Indirect | by SLAT |
| Common Stock | 7,662 | Indirect | by Trust |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 200 shares of Company stock on September 13, 2021 at prices ranging from $637.20 to $637.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 676 shares of Company stock on September 13, 2021 at prices ranging from $638.16 to $638.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 203 shares of Company stock on September 13, 2021 at prices ranging from $639.09 to $639.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 400 shares of Company stock on September 13, 2021 at prices ranging from $642.36 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 151 shares of Company stock on September 13, 2021 at prices ranging from $647.42 to $647.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 962 shares of Company stock on September 13, 2021 at prices ranging from $648.30 to $648.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 838 shares of Company stock on September 13, 2021 at prices ranging from $649.00 to $649.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 1,800 shares of Company stock on September 13, 2021 at prices ranging from $650.19 to $650.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- Represents volume-weighted average price of sales of 3,712 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
- These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
